QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 1 filers reported holding QIAGEN NV in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,043,000 | +2.2% | 108,598 | +0.1% | 0.08% | -4.5% |
| Q3 2016 | $2,977,000 | +166.0% | 108,488 | +111.5% | 0.09% | +140.5% |
| Q2 2016 | $1,119,000 | -11.7% | 51,305 | -9.5% | 0.04% | -15.9% |
| Q1 2016 | $1,267,000 | -26.8% | 56,720 | -9.5% | 0.04% | -27.9% |
| Q4 2015 | $1,732,000 | +2.4% | 62,640 | -4.5% | 0.06% | +1.7% |
| Q3 2015 | $1,692,000 | -1.2% | 65,590 | -5.0% | 0.06% | +17.6% |
| Q2 2015 | $1,712,000 | +0.8% | 69,050 | +2.5% | 0.05% | 0.0% |
| Q1 2015 | $1,698,000 | +14.7% | 67,395 | +6.7% | 0.05% | +15.9% |
| Q4 2014 | $1,481,000 | +4.2% | 63,145 | +1.2% | 0.04% | +2.3% |
| Q3 2014 | $1,421,000 | -4.8% | 62,400 | +2.2% | 0.04% | -6.5% |
| Q2 2014 | $1,493,000 | +11.5% | 61,070 | -3.8% | 0.05% | +12.2% |
| Q1 2014 | $1,339,000 | -10.6% | 63,470 | +1.0% | 0.04% | -18.0% |
| Q4 2013 | $1,497,000 | +32.9% | 62,870 | +19.5% | 0.05% | +28.2% |
| Q3 2013 | $1,126,000 | +16.8% | 52,600 | +8.6% | 0.04% | -32.8% |
| Q2 2013 | $964,000 | – | 48,420 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
| Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
| Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
| Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
| Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
| Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
| CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
| Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
| PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |